[HTML][HTML] Impact of hepatitis B virus genetic variation, integration, and lymphotropism in antiviral treatment and oncogenesis

KCK Lau, KW Burak, CS Coffin - Microorganisms, 2020 - mdpi.com
Chronic Hepatitis B Virus (HBV) infection poses a significant global health burden. Although,
effective treatment and vaccinations against HBV are available, challenges still exist …

[HTML][HTML] Hepatitis B and C in pregnancy and children: a Canadian perspective

AB Mendlowitz, JJ Feld, MJ Biondi - Viruses, 2022 - mdpi.com
In 2016, the World Health Organization released a plan to eliminate viral hepatitis as a
public health threat by 2030. For Canada to achieve the recommended decreases in HBV …

[HTML][HTML] Hepatitis B blood donor screening data: An under-recognized resource for Canadian public health surveillance

SF O'Brien, CN Reedman, C Osiowy, S Bolotin, QL Yi… - Viruses, 2023 - mdpi.com
Hepatitis B surveillance is essential to achieving Canada's goal of eliminating hepatitis B by
2030. Hepatitis B rates, association of infection with vaccine age-eligibility, and risk factors …

[HTML][HTML] Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada

C Osiowy, K Swidinsky, S Haylock-Jacobs, MD Sadler… - JHEP Reports, 2022 - Elsevier
Background & Aims HDV affects 4.5–13% of chronic hepatitis B (CHB) patients globally, yet
the prevalence of HDV infection in Canada is unknown. To investigate the prevalence …

Site-specific cancer incidence by race and immigration status in Canada 2006–2015: a population-based data linkage study

T Malagón, S Morais, P Tope, M El-Zein… - … , Biomarkers & Prevention, 2023 - AACR
Abstract Background: The Canadian Cancer Registry (CCR) does not collect demographic
data beyond age and sex, making it difficult to monitor health inequalities. Using data …

Hepatitis B virus genotype surveillance in Canadian blood donors and a referred patient population, 2016–2021

C Osiowy, E Giles, CF Lowe, N Matic… - Vox …, 2024 - Wiley Online Library
Abstract Background and Objectives Hepatitis B virus (HBV) genotypes (A–H) have a distinct
geographic distribution and are highly associated with the country of birth. Canada has …

Incidence and prediction of HBsAg seroclearance in a prospective multi‐ethnic HBeAg‐negative chronic hepatitis B cohort

NA Terrault, AS Wahed, JJ Feld, SL Cooper… - Hepatology, 2022 - journals.lww.com
Methods The Hepatitis B Research Network (HBRN) is a prospective cohort including 1240
untreated HBeAg‐negative patients (1150 adults, 90 children) with median follow‐up of 5.5 …

[HTML][HTML] Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos (t) ide analogue

A Ramji, K Doucette, C Cooper, GY Minuk… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Hepatitis B virus (HBV) nucleos (t) ide analog (NA) therapy reduces liver
disease but requires prolonged therapy to achieve hepatitis B surface antigen (HBsAg) loss …

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050

MJ Biondi, C Estes, D Razavi-Shearer… - … Open Access Journal, 2023 - cmajopen.ca
Background: The World Health Organization recommends universal birth dose vaccination
for hepatitis B virus (HBV), yet only 3 provinces and territories in Canada provide birth dose …

[HTML][HTML] Hepatitis B virus genotypes in Brazil: Introduction and dissemination

JM Wolf, D Simon, VR Lunge - Infection, Genetics and Evolution, 2021 - Elsevier
Hepatitis B is a viral infectious disease highly spread worldwide with a long evolutionary
history associated with human migrations through the continents and countries. Hepatitis B …